Literature DB >> 15547200

Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance.

Seong Hyun Kim1, Hyo K Lim, Dongil Choi, Won Jae Lee, Seung Hoon Kim, Min Ju Kim, Soon Jin Lee, Jae Hoon Lim.   

Abstract

OBJECTIVE: The purpose of our study was to determine the frequency of bile duct changes after radiofrequency ablation for hepatocellular carcinoma and to evaluate their clinical significance.
MATERIALS AND METHODS: Between April 1999 and August 2003, 389 patients with 521 hepatocellular carcinomas underwent a total of 571 sessions of radiofrequency ablation. The maximum dimension of the tumors measured on sonography was 2.4 +/- 0.9 cm (mean +/- SD) (range, 0.5-5.0 cm). The frequency and type of bile duct changes resulting from radiofrequency ablation, the time interval between radiofrequency ablation and the first appearance of bile duct changes, and the serial changes at follow-up CT were analyzed. Complications related to bile duct changes were also evaluated by reviewing medical records and CT scans.
RESULTS: Bile duct changes occurred in 69 (12%) of 571 sessions and 66 (17%) of 389 patients. Bile duct changes seen on CT included mild dilatation of upstream bile ducts surrounding the ablation zone in 57 patients (82.6%), biloma in the ablation zone in four patients (5.8%), and both in eight patients (11.6%). The mean time interval between radiofrequency ablation and the initial appearance of bile duct change was 1.6 months (range, immediate-9 months). Most (87%) of the 69 patients with bile duct changes showed no progression on follow-up CT, and only nine (13%) had slight progression. All patients but one, in whom cholangitis developed, had no major complications requiring specific treatment during the follow-up period.
CONCLUSION: Although bile duct changes were frequent after the radiofrequency ablation of hepatocellular carcinoma, most were of no clinical significance, and major complications requiring additional treatment were rare.

Entities:  

Mesh:

Year:  2004        PMID: 15547200     DOI: 10.2214/ajr.183.6.01831611

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 2.  Focal intrahepatic strictures: a review of diagnosis and management.

Authors:  David Yeo; Marcos Vinicius Perini; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

3.  Radioembolization for hepatocellular carcinoma complicated by biliary stricture.

Authors:  Jeet Minocha; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 4.  Complications of intraoperative radiofrequency ablation of liver metastases.

Authors:  Tsiriniaina Razafindratsira; Milène Isambert; Serge Evrard
Journal:  HPB (Oxford)       Date:  2010-12-07       Impact factor: 3.647

5.  Imaging to optimize liver tumor ablation.

Authors:  Bradley B Pua; Constantinos T Sofocleous
Journal:  Imaging Med       Date:  2010-08

Review 6.  Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.

Authors:  Alexandre Zanchenko Fonseca; Stephanie Santin; Luiz Guilherme Lisboa Gomes; Jaques Waisberg; Marcelo Augusto Fontenelle Ribeiro
Journal:  World J Hepatol       Date:  2014-03-27

7.  Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.

Authors:  Man-Xia Lin; Jie-Yi Ye; Wen-Shuo Tian; Ming Xu; Bo-Wen Zhuang; Ming-De Lu; Xiao-Yan Xie; Ming Kuang
Journal:  Dig Dis Sci       Date:  2017-02-15       Impact factor: 3.199

8.  Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients.

Authors:  Wen-Tao Kong; Wei-Wei Zhang; Yu-Dong Qiu; Tie Zhou; Jun-Lan Qiu; Wei Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

9.  Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations.

Authors:  Dong Ik Cha; Min Woo Lee; Hyunchul Rhim; Dongil Choi; Young-sun Kim; Hyo K Lim
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

10.  Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study.

Authors:  Natally Horvat; Jose de Arimateia B Araujo-Filho; Antonildes N Assuncao-Jr; Felipe Augusto de M Machado; John A Sims; Camila Carlos Tavares Rocha; Brunna Clemente Oliveira; Joao Vicente Horvat; Claudia Maccali; Anna Luísa Boschiroli Lamanna Puga; Aline Lopes Chagas; Marcos Roberto Menezes; Giovanni Guido Cerri
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.